A research team led by chemistry professor Paul Hergenrother reports a new molecule's ability to fight drug-resistant bacteria in lab experiments and in mice with pneumonia and urinary tract infections. The researchers say fabimycin may one day be used to treat antibiotic-resistant infections in humans.